Associations between long term use of acid suppressing drugs and risk of oesophageal adenocarcinoma (OA) compared with non-users stratified by treatment indication

ExposureControlsOAOR (95% CI)
Oesophageal125 (1.2)16 (5.6)5.42 (3.13–9.39)
Other indications218 (2.2)10 (3.5)1.74 (0.90–3.34)